153 related articles for article (PubMed ID: 22619125)
41. [Gene abnormalities in melanoma and signal transduction antagonists].
Takada M
Gan To Kagaku Ryoho; 2013 Apr; 40(4):453-7. PubMed ID: 23894754
[No Abstract] [Full Text] [Related]
42. [Genetic diversity and immunological characteristics of malignant melanoma: the therapeutic spectrum].
Doma V; Gulya E
Orv Hetil; 2015 Apr; 156(15):583-91. PubMed ID: 25845317
[TBL] [Abstract][Full Text] [Related]
43. Impact of Reflex Testing for BRAF Mutational Status in Advanced Melanoma.
Tsang M; Petkiewicz S
Arch Pathol Lab Med; 2022 Dec; 146(12):1535-1539. PubMed ID: 35344989
[TBL] [Abstract][Full Text] [Related]
44. Mutational profiling in melanocytic tumors: multiple somatic mutations and clinical implications.
Richetta AG; Silvestri V; Giancristoforo S; Rizzolo P; D'Epiro S; Graziano V; Mattozzi C; Navazio AS; Falchetti M; Calvieri S; Ottini L
Oncology; 2014; 86(2):104-8. PubMed ID: 24457427
[TBL] [Abstract][Full Text] [Related]
45. [Prognostic and predictive markers of malignant melanoma].
Rásó E; Barbai T; Gyõrffy B; Tímár J
Magy Onkol; 2013 Jun; 57(2):79-83. PubMed ID: 23795352
[TBL] [Abstract][Full Text] [Related]
46. Mutation analysis in malignant melanoma.
Gaiser MR; Stadler R; Schirmacher P; Dietel M; Enk A
J Dtsch Dermatol Ges; 2013 May; 11 Suppl 4():2-10. PubMed ID: 23721634
[No Abstract] [Full Text] [Related]
47. Reflex Molecular Testing in Melanoma Diagnosis: When Should
Zhou S; Sivachandran S; Sikorski D; Xu HH; Lagacé F; Claveau J; Salopek TG; Gniadecki R; Litvinov IV
J Cutan Med Surg; 2022; 26(2):201-202. PubMed ID: 34494908
[No Abstract] [Full Text] [Related]
48. Driver KIT mutations in melanoma cluster in four hotspots.
Dumaz N; André J; Sadoux A; Laugier F; Podgorniak MP; Mourah S; Lebbé C
Melanoma Res; 2015 Feb; 25(1):88-90. PubMed ID: 25304235
[TBL] [Abstract][Full Text] [Related]
49. BRAF pyrosequencing analysis aided by a lookup table.
Olson MT; Harrington C; Beierl K; Chen G; Thiess M; O'Neill A; Taube JM; Zeiger MA; Lin MT; Eshleman JR
Am J Clin Pathol; 2014 May; 141(5):639-47. PubMed ID: 24713734
[TBL] [Abstract][Full Text] [Related]
50. [Molecular testing in malignant melanoma].
Dundr P; Staněk L; Němejcová K; Jakša R
Cesk Patol; 2014 Jul; 50(3):127-31. PubMed ID: 25186593
[TBL] [Abstract][Full Text] [Related]
51. Personalized treatments of cancer patients: a reality in daily practice, a costly dream or a shared vision of the future from the oncology community?
Arnedos M; Soria JC; Andre F; Tursz T
Cancer Treat Rev; 2014 Dec; 40(10):1192-8. PubMed ID: 25441102
[TBL] [Abstract][Full Text] [Related]
52. Fast and Easy-to-Perform BRAF Testing in Melanoma Samples: An Accessible Tool for Pathologists With no Experience in Molecular Analyses.
Barel F; Uguen A
Appl Immunohistochem Mol Morphol; 2019 Aug; 27(7):535-536. PubMed ID: 30320660
[TBL] [Abstract][Full Text] [Related]
53. BRAF-Mutated Melanoma Journey in Latin America: Expert Recommendations From Diagnosis to Treatment.
Bravo-Garzón MA; Bornstein-Quevedo L; Camargo VP; Sanku G; Jansen AM; Macedo MP; Rico-Restrepo M; Chacón M
Cancer Control; 2024; 31():10732748241251572. PubMed ID: 38751033
[TBL] [Abstract][Full Text] [Related]
54. Guidelines for biomarker testing in metastatic melanoma: a National Consensus of the Spanish Society of Pathology and the Spanish Society of Medical Oncology.
Martín-Algarra S; Fernández-Figueras MT; López-Martín JA; Santos-Briz A; Arance A; Lozano MD; Berrocal A; Ríos-Martín JJ; Espinosa E; Rodríguez-Peralto JL; ;
Clin Transl Oncol; 2014 Apr; 16(4):362-73. PubMed ID: 24129426
[TBL] [Abstract][Full Text] [Related]
55. A case of unknown primary melanoma detected with a BRAF gene mutation from a pleural fluid cell block.
Yamamoto S; Kuriyama H; Kashiwada-Nakamura K; Kajihara I; Makino K; Aoi J; Miyashita A; Yoshida C; Kubo Y; Fukushima S
J Dermatol; 2023 Sep; 50(9):e305-e306. PubMed ID: 37088959
[No Abstract] [Full Text] [Related]
56. Molecular techniques for predicting behaviour in melanocytic neoplasms.
Lee CY; Gerami P
Pathology; 2016 Feb; 48(2):142-6. PubMed ID: 27020386
[TBL] [Abstract][Full Text] [Related]
57. On the cusp of a revolution: melanoma molecular diagnostics.
Carlson JA
J Am Acad Dermatol; 2013 Oct; 69(4):646-7. PubMed ID: 24034371
[No Abstract] [Full Text] [Related]
58. [Molecular pathology of skin melanoma].
Tímár J; Ladányi A
Magy Onkol; 2022 Jun; 66(2):101-108. PubMed ID: 35724386
[TBL] [Abstract][Full Text] [Related]
59. Analysis of the genome to personalize therapy for melanoma.
Davies MA; Samuels Y
Oncogene; 2010 Oct; 29(41):5545-55. PubMed ID: 20697348
[TBL] [Abstract][Full Text] [Related]
60. Improving care of melanoma patients through efficient, integrated cellular-molecular pathology workflows using tissue samples with low tumour nuclear content.
Finall A; Murphy K; Frazer RD
J Clin Pathol; 2023 Sep; 76(9):612-617. PubMed ID: 35428674
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
